ACHE and Alzheimer disease: In other words, these findings suggest that under baseline conditions, AD patients with high AChE levels also have a high number of nAChRs in the brain, most likely reflecting a physiological equilibrium (or compensation) between available concentration and/or duration of action of ACh and levels of AChE-S activity in the synaptic clefts.